THE EFFECT OF 17α-ETHYL-19-NORTESTOSTERONE AND 17α-ETHYL-19-NORTESTOSTERONE 3-ENOL-PROPIONATE ON GROWTH AND ENDOCRINE FUNCTION IN NORMAL YOUNG MALES OF SHORT STATURE

Author:

Geller Jack

Abstract

ABSTRACT 8 courses of norethandrolone by mouth and 5 courses of 17-ethyl-19-nortestosterone 3-enol-propionate (SC-7294) i. m. were administered for 6-12 month periods to a total of 11 patients with short stature but no other abnormality. During the mean treatment period of 6 months in the combined group of patients standard height age Δ increased an average of 12 months; corrected height age Δ, a measurement introduced to evaluate growth rates in patients undergoing a spontaneous growth spurt, averaged 12.1 months and bone age maturation increased 11.5 months. Out of 13 total courses of treatment, 8 with norethandrolone and 5 with SC-7294, predicted ultimate stature appeared to have been favorably affected in 7 instances, unchanged in 4 and reduced in 2. In 7 of the patients, additional observations were made during a 6-9 month period following initial therapy. Cumulative data over a 12-15 month period in these 7 patients indicated that standard and corrected height age Δ's were equal to or exceeded bone age Δ's during the same time interval in 5 out of 7 of the patients. There was no evidence of drug toxicity to the liver; urinary 17-ketosteroids fell in a majority of patients after 6 months of therapy; no significant changes in the 17-hydroxy corticoids appeared. The drugs did not appear to suppress the urinary gonadotrophins in the dosage administered. Significant weight gain accompanied therapy in all instances. This preliminary experience indicates that carefully regulated doses of norethandrolone and SC-7294 are safe and useful for increasing immediate stature in most patients with short stature of non-endocrine origins. The drugs should be given for 6 month intervals only; ratios must be determined at the end of therapy and again a 6 month follow-up period before deciding upon the advisability of retreatment. No claim for or against the usefulness of these drugs in increasing ultimate stature can be made on the basis of this study.

Publisher

Bioscientifica

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism

Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Stunted growth with more or less normal appearance;European Journal of Pediatrics;1982-12

2. The Use of Anabolic-Androgenic Steroids in Childhood and Adolescence;Anabolic-Androgenic Steroids;1976

3. 5 Sexual precocity;Clinics in Endocrinology and Metabolism;1975-03

4. Structure and effects of anabolic steroids;Pharmacology & Therapeutics. Part B: General and Systematic Pharmacology;1975

5. Oxandrolone for Growth Promotion in Turner Syndrome;Archives of Pediatrics & Adolescent Medicine;1973-03-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3